{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:03:12Z","timestamp":1793473392553,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NCI","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1245\/s10434-023-13495-3","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:09:26Z","timestamp":1682604566000},"page":"4936-4945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Impact of Positive Surgical Margins in Gastric Adenocarcinoma in the Era of Preoperative Therapy"],"prefix":"10.1245","volume":"30","author":[{"given":"Yuki","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Agnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannelyn S.","family":"Estrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela","family":"Blum Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffer A.","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Badgwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"issue":"26","key":"13495_CR1","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1200\/JCO.20.02914","volume":"39","author":"YK Kang","year":"2021","unstructured":"Kang YK, Yook JH, Park YK, et al. PRODIGY: a phase III study of neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 versus surgery and adjuvant S-1 for resectable advanced gastric cancer. J Clin Oncol. 2021;39(26):2903\u201313.","journal-title":"J Clin Oncol."},{"issue":"8","key":"13495_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S1470-2045(21)00297-7","volume":"22","author":"X Zhang","year":"2021","unstructured":"Zhang X, Liang H, Li Z, et al. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial. The Lancet Oncol. 2021;22(8):1081\u201392.","journal-title":"The Lancet Oncol."},{"issue":"2","key":"13495_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, et al. Gastric cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Cancer Netw."},{"issue":"1","key":"13495_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer A","year":"2021","unstructured":"Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1\u201321.","journal-title":"Gastric Cancer."},{"issue":"10","key":"13495_CR5","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1245\/s10434-009-0616-0","volume":"16","author":"S-Y Wang","year":"2009","unstructured":"Wang S-Y, Yeh C-N, Lee H-L, et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol. 2009;16(10):2738\u201343.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"13495_CR6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/jso.22022","volume":"104","author":"T Nagata","year":"2011","unstructured":"Nagata T, Ichikawa D, Komatsu S, et al. Prognostic impact of microscopic positive margin in gastric cancer patients. J Surg Oncol. 2011;104(6):592\u20137.","journal-title":"J Surg Oncol."},{"issue":"8","key":"13495_CR7","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1245\/s10434-013-2950-5","volume":"20","author":"KA Bickenbach","year":"2013","unstructured":"Bickenbach KA, Gonen M, Strong V, Brennan MF, Coit DG. Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol. 2013;20(8):2663\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"13495_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12893-020-00744-5","volume":"20","author":"Y Kumazu","year":"2020","unstructured":"Kumazu Y, Hayashi T, Yoshikawa T, et al. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients. BMC Surg. 2020;20(1):95.","journal-title":"BMC Surg."},{"issue":"8","key":"13495_CR9","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jclinpath-2019-206305","volume":"73","author":"B Zhao","year":"2020","unstructured":"Zhao B, Lu H, Bao S, et al. Impact of proximal resection margin involvement on survival outcome in patients with proximal gastric cancer. J Clin Pathol. 2020;73(8):470\u20135.","journal-title":"J Clin Pathol."},{"issue":"4","key":"13495_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00595-020-02110-7","volume":"51","author":"S Fujita","year":"2021","unstructured":"Fujita S, Oshima Y, Yajima S, et al. What are the important prognostic factors in gastric cancer with positive duodenal margins? A multi-institutional analysis. Surg Today. 2021;51(4):561\u20137.","journal-title":"Surg Today."},{"issue":"4","key":"13495_CR11","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00595-021-02365-8","volume":"52","author":"K Nakanishi","year":"2022","unstructured":"Nakanishi K, Kanda M, Ito S, et al. Prognostic impact of a microscopic positive margin in patients undergoing gastrectomy for gastric cancer: a propensity score-matched analysis of a multi-institutional dataset. Surg Today. 2022;52(4):559\u201366.","journal-title":"Surg Today."},{"issue":"12","key":"13495_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.ejso.2019.06.026","volume":"45","author":"RH Tu","year":"2019","unstructured":"Tu RH, Lin JX, Wang W, et al. Pathological features and survival analysis of gastric cancer patients with positive surgical margins: a large multicenter cohort study. Eur J Surg Oncol. 2019;45(12):2457\u201364.","journal-title":"Eur J Surg Oncol."},{"issue":"1","key":"13495_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s10120-015-0589-6","volume":"20","author":"M Bissolati","year":"2017","unstructured":"Bissolati M, Desio M, Rosa F, et al. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer: an Italian multicenter study. Gastric Cancer. 2017;20(1):70\u201382.","journal-title":"Gastric Cancer."},{"issue":"24","key":"13495_CR14","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.3748\/wjg.v12.i24.3883","volume":"12","author":"JG Shen","year":"2006","unstructured":"Shen JG, Cheong JH, Hyung WJ, Kim J, Choi SH, Noh SH. Influence of a microscopic positive proximal margin in the treatment of gastric adenocarcinoma of the cardia. World J Gastroenterol. 2006;12(24):3883\u20136.","journal-title":"World J Gastroenterol."},{"issue":"3","key":"13495_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/jso.24110","volume":"113","author":"LM Postlewait","year":"2016","unstructured":"Postlewait LM, Maithel SK. The importance of surgical margins in gastric cancer. J Surg Oncol. 2016;113(3):277\u201382.","journal-title":"J Surg Oncol."},{"issue":"2","key":"13495_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10120-021-01255-9","volume":"25","author":"S Mine","year":"2022","unstructured":"Mine S, Kurokawa Y, Takeuchi H, et al. Postoperative complications after a transthoracic esophagectomy or a transhiatal gastrectomy in patients with esophagogastric junctional cancers: a prospective nationwide multicenter study. Gastric Cancer. 2022;25(2):430\u20137.","journal-title":"Gastric Cancer."},{"issue":"6","key":"13495_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.20517\/2394-4722.2018.15","volume":"4","author":"R Makuuchi","year":"2018","unstructured":"Makuuchi R, Irino T, Tanizawa Y, Bando E, Kawamura T, Terashima M. Pancreaticoduodenectomy for gastric cancer. J Cancer Metastasis Treat. 2018;4(6):26.","journal-title":"J Cancer Metastasis Treat."},{"issue":"10","key":"13495_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725\u201330.","journal-title":"N Engl J Med."},{"issue":"1","key":"13495_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med."},{"issue":"6","key":"13495_CR20","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s10120-018-0832-z","volume":"21","author":"N Ikoma","year":"2018","unstructured":"Ikoma N, Das P, Hofstetter W, et al. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006\u20132014 using propensity score matching. Gastric Cancer. 2018;21(6):1004\u201313.","journal-title":"Gastric Cancer."},{"issue":"5","key":"13495_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s11605-019-04422-7","volume":"24","author":"N Ikoma","year":"2020","unstructured":"Ikoma N, Agnes A, Chen HC, et al. Linitis plastica: a distinct type of gastric cancer. J Gastrointest Surg. 2020;24(5):1018\u201325.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"13495_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The Eighth Edition AJCC Cancer Staging Manual Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin."},{"key":"13495_CR23","unstructured":"Burgart LJ, Chopp WV, Jain D. Protocol for the examination of specimens from patients with carcinoma of the stomach Version: 4.2.1.0. College of American Pathologists; 2021."},{"issue":"1","key":"13495_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jamcollsurg.2015.04.004","volume":"221","author":"B Badgwell","year":"2015","unstructured":"Badgwell B, Blum M, Estrella J, et al. Predictors of survival in patients with resectable gastric cancer treated with preoperative chemoradiation therapy and gastrectomy. J Am Coll Surg. 2015;221(1):83\u201390.","journal-title":"J Am Coll Surg."},{"issue":"14","key":"13495_CR25","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1200\/JCO.2004.01.015","volume":"22","author":"JA Ajani","year":"2004","unstructured":"Ajani JA, Mansfield PF, Janjan N, et al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004;22(14):2774\u201380.","journal-title":"J Clin Oncol."},{"issue":"24","key":"13495_CR26","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1200\/JCO.2006.06.4840","volume":"24","author":"JA Ajani","year":"2006","unstructured":"Ajani JA, Winter K, Okawara GS, et al. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol. 2006;24(24):3953\u20138.","journal-title":"J Clin Oncol."},{"issue":"11","key":"13495_CR27","first-page":"6283","volume":"34","author":"P Aurello","year":"2014","unstructured":"Aurello P, Magistri P, Nigri G, et al. Surgical management of microscopic positive resection margin after gastrectomy for gastric cancer: a systematic review of gastric R1 management. Anticancer Res. 2014;34(11):6283\u20138.","journal-title":"Anticancer Res."},{"issue":"13","key":"13495_CR28","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1245\/s10434-014-3834-z","volume":"21","author":"MH Squires 3rd","year":"2014","unstructured":"Squires MH 3rd, Kooby DA, Pawlik TM, et al. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative. Ann Surg Oncol. 2014;21(13):4202\u201310.","journal-title":"Ann Surg Oncol."},{"key":"13495_CR29","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","volume":"3","author":"JA Ajani","year":"2017","unstructured":"Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036.","journal-title":"Nat Rev Dis Primers."},{"issue":"1","key":"13495_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s10120-021-01238-w","volume":"25","author":"Y Muneoka","year":"2022","unstructured":"Muneoka Y, Ohashi M, Ishizuka N, et al. Risk factors and oncological impact of positive resection margins in gastrectomy for cancer: are they salvaged by an additional resection? Gastric Cancer. 2022;25(1):287\u201396.","journal-title":"Gastric Cancer."},{"issue":"3\u20134","key":"13495_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000236018","volume":"77","author":"C Li","year":"2009","unstructured":"Li C, Oh SJ, Kim S, et al. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009;77(3\u20134):197\u2013204.","journal-title":"Oncology."},{"issue":"4","key":"13495_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5946\/ce.2016.057","volume":"49","author":"K Jung","year":"2016","unstructured":"Jung K, Park MI, Kim SE, Park SJ. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc. 2016;49(4):336\u201345.","journal-title":"Clin Endosc."},{"issue":"1","key":"13495_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12957-020-01987-5","volume":"18","author":"XH Song","year":"2020","unstructured":"Song XH, Zhang WH, Kai L, et al. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. World J Surg Oncol. 2020;18(1):204.","journal-title":"World J Surg Oncol."},{"issue":"6","key":"13495_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jso.20731","volume":"95","author":"BC Cho","year":"2007","unstructured":"Cho BC, Jeung HC, Choi HJ, et al. Prognostic impact of resection margin involvement after extended (D2\/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute. J Surg Oncol. 2007;95(6):461\u20138.","journal-title":"J Surg Oncol."},{"key":"13495_CR35","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:1005.","journal-title":"Ann Oncol."},{"issue":"24","key":"13495_CR36","doi-asserted-by":"publisher","first-page":"7571","DOI":"10.3748\/wjg.v21.i24.7571","volume":"21","author":"P Aurello","year":"2015","unstructured":"Aurello P, Sirimarco D, Magistri P, et al. Management of duodenal stump fistula after gastrectomy for gastric cancer: systematic review. World J Gastroenterol. 2015;21(24):7571\u20136.","journal-title":"World J Gastroenterol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-13495-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-13495-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T16:25:21Z","timestamp":1688487921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-13495-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["13495"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-13495-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NI received a research grant from Intuitive Surgical. PD received honoraria from Bayer, ASTRO, ASCO, Conveners LLC, Physicians Education Resource, and Imedex.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and regional) and with the Helsinki Declaration of 1975, as revised in 1983. Because this was a retrospective study of de-identified patients, no informed consent was required. Ethics approval for this work was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}